News | August 06, 2021
Strides to acquire US manufacturing facility of Endo for $24 mn
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
He will be stationed at the company HQ in Bengaluru, India
CDSCO to fast-track trials and approval for COVID19 vaccine
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
It had an estimated market size of US $ 32 million as of June 2021
Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
It works as an adjunct to standard care based on robust clinical trials
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Subscribe To Our Newsletter & Stay Updated
